Heart disease develops over decades—the visible crisis is just the endpoint
For decades, medicine has treated heart disease as a concern that arrives in middle age, but a long-running Northwestern Medicine study suggests the clock starts earlier than we assumed — particularly for men. Tracking thousands of adults across forty years, researchers found that men's cardiovascular risk begins its decisive climb around age thirty-five, reaching disease thresholds nearly a decade before women do, even as the traditional risk factors between the sexes have grown more alike. The finding asks a quiet but urgent question of modern medicine: if the danger begins in early adulthood, why does the system still wait until forty to look?
- Men are reaching a 5% cardiovascular disease threshold at age 50.5 — seven years ahead of women — and for coronary heart disease specifically, the gap stretches beyond a decade.
- The acceleration begins around age 35, yet standard screening protocols don't target men until after 40, leaving a critical window of rising risk essentially unwatched.
- Converging risk factors between men and women — similar smoking rates, blood pressure, cholesterol, and diabetes patterns — have not closed the disease gap, pointing to biological or social forces medicine hasn't fully mapped.
- Young men visit doctors for preventive care at less than a quarter the rate of young women, meaning rising blood pressure and cholesterol often go undetected until a crisis forces the encounter.
- Researchers are urging adoption of the American Heart Association's PREVENT equations, which can assess cardiovascular risk starting at age 30, as a practical first step toward earlier intervention.
A forty-year study from Northwestern Medicine has quietly dismantled one of medicine's working assumptions: that heart disease is a concern men can defer until middle age. Following more than five thousand Black and white adults from their late teens through 2020, researchers found that men's cardiovascular risk doesn't wait. It begins climbing sharply around thirty-five.
The numbers are precise and telling. Men reach a five percent incidence of cardiovascular disease — heart attacks, strokes, and heart failure combined — at roughly fifty and a half years old. Women don't cross that same threshold until fifty-seven and a half. For coronary heart disease specifically, the kind that triggers heart attacks, men arrive at a two percent incidence more than a decade before women do.
What makes the finding particularly striking is that it holds even as the traditional risk factors between men and women have converged. Smoking patterns have shifted. Blood pressure and cholesterol profiles have grown more similar. Diabetes is no longer predominantly a male condition. Yet the disease gap hasn't narrowed. Senior author Alexa Freedman notes that heart disease is a decades-long process — the visible crisis is simply the endpoint of something that began quietly in young adulthood.
High blood pressure explained part of the gap, but not most of it. Biological mechanisms not yet fully understood, or social patterns outside standard screening measures, appear to be doing significant work beneath the surface.
The practical problem is this: American medicine still directs heart disease screening at adults over forty. That guideline misses the window entirely. The American Heart Association has developed risk prediction tools that function starting at age thirty, but they remain outside standard practice. Meanwhile, women aged eighteen to forty-four visit doctors for routine checkups at more than four times the rate men do — meaning young men often progress, unmonitored, toward a crisis that could have been interrupted.
The researchers' message is direct: screening must start earlier, preventive visits must happen more often, and the years between thirty-five and fifty must be treated as a time for intervention rather than observation. The data has shifted. The question is whether medical practice will follow.
A study spanning four decades has upended assumptions about when men need to start worrying about their hearts. Researchers at Northwestern Medicine tracked more than five thousand Black and white adults from their late teens through 2020, watching as their cardiovascular systems aged. What they found was stark: men's risk of heart disease doesn't wait until middle age. It begins its sharp climb around thirty-five.
The numbers tell a precise story. Men reach a five percent incidence of cardiovascular disease—heart attacks, strokes, heart failure combined—at roughly fifty and a half years old. Women don't hit that same threshold until fifty-seven and a half. That seven-year gap matters. It matters more when you look at coronary heart disease specifically, the kind that triggers heart attacks. Men reach a two percent incidence more than a decade before women do. The divergence is real, measurable, and earlier than current medical practice accounts for.
What makes this finding surprising is that it persists despite convergence in the risk factors themselves. Smoking rates have shifted. Blood pressure and cholesterol patterns have become more similar between men and women. Diabetes is no longer a predominantly male problem. Yet the gap in actual disease hasn't narrowed. Alexa Freedman, the study's senior author at Northwestern's Feinberg School of Medicine, notes that heart disease develops over decades—the visible crisis is just the endpoint of a long, quiet process. Early markers show up in young adulthood. By the time a man reaches thirty-five, something in his biology or his circumstances is already accelerating his risk in ways that don't show up in women the same way.
The researchers examined the usual suspects: blood pressure, cholesterol, blood sugar, smoking, diet, exercise, weight. High blood pressure explained some of the gap. But not all of it. Not even most of it. Something else is at work—biological factors not yet fully understood, or social patterns not captured by standard screening measures. The study's population was relatively young throughout the follow-up period, everyone under sixty-five at the end, which means stroke and heart failure may reveal different patterns as people age further. But the coronary heart disease signal is unmistakable.
Here's where the practical problem emerges: American medicine still targets heart disease screening at adults over forty. That guideline misses the window. By forty, men in their mid-thirties have already begun their accelerated climb. The American Heart Association has developed risk prediction equations that work starting at age thirty, but they're not yet standard practice. Freedman and her colleagues are pushing for adoption of these tools, particularly for young men.
There's also a behavioral dimension. Women aged eighteen to forty-four visit their doctors for routine checkups at more than four times the rate men do. That gap in preventive care visits is itself a risk factor—not because checkups cure disease, but because they're the moment when risk factors get identified and addressed. A young man who never sees a doctor can't be told his blood pressure is climbing or his cholesterol is drifting upward. He can't be counseled about smoking or exercise. He simply progresses, unmonitored, toward the crisis that will eventually arrive.
The study's implication is straightforward but requires a shift in how medicine thinks about men's health. Screening needs to start earlier. Preventive care visits need to happen more often. The window between thirty-five and fifty is not a time to wait and see. It's the time when intervention actually works, when risk factors can still be modified, when the trajectory can still be bent. The question now is whether the medical system will adjust its practices to match what the data actually shows.
Notable Quotes
Heart disease develops over decades, with early markers detectable in young adulthood. Screening at an earlier age can help identify risk factors sooner, enabling preventive strategies that reduce long-term risk.— Alexa Freedman, Northwestern University Feinberg School of Medicine
Encouraging preventive care visits among young men could be an important opportunity to improve heart health and lower cardiovascular disease risk.— Alexa Freedman
The Hearth Conversation Another angle on the story
Why does this gap exist if men and women now have similar risk factors?
That's the unsettling part. The researchers controlled for all the obvious culprits—blood pressure, cholesterol, smoking, weight—and the gap remained. It suggests either biological differences we don't fully understand yet, or social patterns that don't show up in standard measurements. Maybe how men respond to stress, or sleep patterns, or something about male physiology itself.
So screening earlier would catch what, exactly?
The early markers. High blood pressure that's just starting to climb. Cholesterol beginning to drift. Inflammation signals. The point is to identify these things at thirty-five, not at forty-five when they've been progressing for a decade. Once you know the risk exists, you can actually do something about it.
But men don't go to the doctor as often. How do you screen someone who won't show up?
That's the real barrier. Women visit for routine checkups four times more often than men in that age group. You can have the best screening tool in the world, but it doesn't matter if the person never walks into the clinic. The study is really pointing at two problems at once: men need earlier screening, and men need to actually use preventive care.
Is this saying men are biologically destined to have earlier heart disease?
Not destined. But something about being male—whether it's hormonal, genetic, or behavioral—accelerates the process. The encouraging part is that risk factors are still modifiable. You can lower blood pressure, quit smoking, exercise more. The window just needs to open earlier than we've been assuming.
What happens if nothing changes?
Men keep having heart attacks in their fifties while they could have prevented them in their thirties. The study is essentially saying we're missing a crucial intervention window by following guidelines built on outdated assumptions.